Novel oral anticoagulants in non-valvular atrial fibrillation

TS Potpara, GYH Lip - Best Practice & Research Clinical Haematology, 2013 - Elsevier
Atrial fibrillation (AF) confers a significant risk of stroke or systemic thromboembolism. Oral
anticoagulation is the most effective therapy for AF-related stroke prevention. A decision to …
被引用次数：39 相关文章

Novel oral anticoagulants in non-valvular atrial fibrillation

TS Potpara, GYH Lip - Best Practice & Research Clinical Haematology, 2013 - infona.pl
Atrial fibrillation (AF) confers a significant risk of stroke or systemic thromboembolism. Oral
anticoagulation is the most effective therapy for AF-related stroke prevention. A decision to …

Novel oral anticoagulants in non-valvular atrial fibrillation.

TS Potpara, GY Lip - Best Practice & research. Clinical …, 2013 - europepmc.org
Atrial fibrillation (AF) confers a significant risk of stroke or systemic thromboembolism. Oral
anticoagulation is the most effective therapy for AF-related stroke prevention. A decision to …

Novel oral anticoagulants in non-valvular atrial fibrillation

TS Potpara, GYH Lip - Best practice & research. Clinical …, 2013 - pubmed.ncbi.nlm.nih.gov
Atrial fibrillation (AF) confers a significant risk of stroke or systemic thromboembolism. Oral
anticoagulation is the most effective therapy for AF-related stroke prevention. A decision to …